CT/NIHSS mismatch for detection of salvageable brain in acute stroke triage beyond the 3-hour time window: Overrated or undervalued?

Stroke

Volumn 38, Issue 7, 2007, Pages 2028-2029

  Lev, Michael H ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Brain imaging; Brain infarction; Brain ischemia; CT; Diffusion weighted imaging; Mismatch; Neuroradiology

Indexed keywords

DESMOTEPLASE; RETEPLASE;

BLOOD CLOT LYSIS; BRAIN CIRCULATION; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; EDITORIAL; EMBOLECTOMY; FIBRINOLYTIC THERAPY; FOOD AND DRUG ADMINISTRATION; HUMAN; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; SAFETY; STROKE; UNIVARIATE ANALYSIS;

BRAIN; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; HUMANS; MAGNETIC RESONANCE IMAGING; THROMBOLYTIC THERAPY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TRIAGE;

EID: 34347339582     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.488379     Document Type: Editorial

References (20)

1. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S, for the DAIS Study Group. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36:66-73.
2. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Kees, KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W, for the DEDAS Investigators. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006;37:1227-1231.
3. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP; DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60:508-517.
4. Thomalla G, Schwark C, Sobesky J, Bluhmki E, Fiebach JB, Fiehler J, Weber OZ, Kucinski T, Juettler E, Ringleb PA, Zeumer H, Weiller C, Hacke W, Schellinger PD, Rother for the MRI in Acute Stroke Study Group of the German Competence Network Stroke. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke. 2006;37:852-858.
5. Kohrmann M, Juttler E, Fiebach JB, Huttner HB, Siebert S, Schwark C, Ringleb PA, Schellinger PD, Hacke W. MRI versus CT-based thrombolysis treatment within and beyond the 3 hour time window after stroke onset: a cohort study. Lancet Neurol. 2006;5:661-667.
6. Schaefer PW, Roccatagliata L, Ledezma C, Hoh B, Schwamm LH, Koroshetz W, Gonzalez RG, Lev MH. First-pass quantitative CT perfusion identifies thresholds for salvageable penumbra in acute stroke patients treated with intraarterial therapy. AJNR Am J Neuroradiol. 2006;27:20-25.
7. Murphy BD, Fox AJ, Lee DH, Sahlas DJ, Black SE, Hogan MJ, Coutts SB, Demchuk AM, Goyal M, Aviv RI, Symons S, Gulka IB, Beletsky V, Pelz D, Hachinski V, Chan R, Lee T-Y. Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements. Stroke. 2006;37:1771-1777.
8. Wintermark M, Flanders AE, Velthuis B, Meuli R, van Leeuwen M, Goldsher D, Pineda C, Serena J, van der Schaaf I, Waaijer A, Anderson J, Nesbit G, Gabriely I, Medina V, Quiles A, Pohlman S, Quist M, Schnyder P, Bogousslavsky J, Dilllon WP, Pedraza S. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke. 2006;37:979-985.
9. Messé SR, Kasner SE, Chalela JA, Cucchiara B, Demchuk AM, Hill MD, Warach S. CT-NIHSS mismatch does not correlate with MRI diffusion-perfusion mismatch. Stroke. 2007;38:2079-2084.
10. Davis SM, Donnan GA, Butcher KS, Parsons M. Selection of thrombolytic therapy beyond 3 hours using magnetic resonance imaging. Curr Opin Neurol. 2005;18:47-52.
11. Kent DM, Hill MD, Ruthazer R, Coutts SB, Demchuk AM, Dzialowski I, Wunderlich O, von Kummer R. "Clinical-CT mismatch" and the response to systemic thrombolytic therapy in acute ischemic stroke. Stroke. 2005;36:1695-1699.
12. Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, Hill MD, Patronas N, Latour L, Warach S. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369:293-298.
13. Reineck LA, Agarwal S, Hillis AE. "Diffusion-clinical mismatch" is associated with potential for early recovery of aphasia. Neurology. 2005;64:828-833.
14. Menezes NM, Ay H, Wang Zhu M, Lopez CJ, Singhal AB, Karonen JO, Aronen HJ, Liu Y, Nuutinen J, Koroshetz WJ, Sorensen AG. The real estate factor: quantifying the impact of infarct location on stroke severity. Stroke. 2007;38:194-197.
15. Prosser J, Butcher K, Allport L, Parsons M, MacGregor L, Desmond P, Tress B, Davis S. Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke. 2005;36:1700-1704.
16. Tei H, Uchiyama S, Usui T. Clinical-diffusion mismatch defined by NIHSS and ASPECTS in non-lacunar anterior circulation infarction. J Neurol. 2007;254:340-346.
17. Buck BH, Liebeskind DS, Bang OY, Alger J, Starkman S, Ovbiagele B, Kim D, Sanossian N, Villablanca P, Salamon N, Jahan R, Duckweiler G, Vinuela F, Vespa P, Ali L, Saver JL. Improved clinical-diffusion mismatch identification of penumbral tissue by patient severity adjustment. Abstracts From the 2007 International Stroke Conference, Stroke. 2007;38:465.
18. Singer OC, Sitzer M, du Mesnil de Rochemont R, Neumann-Haefelin T. Practical limitations of acute stroke MRI due to patient-related problems. Neurology. 2004;62:1848-1849.
19. Mulherin S, Miller W. Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation. Ann Intern Med. 2002;137:598-602.
20. Wintermark M, Meuli R, Browaeys P, Reichhart M, Bogousslavsky J, Schnyder P, Michel P. Comparison of CT perfusion and angiography and MRI in selecting stroke patients for acute treatment. Neurology. 2007;68:694-697.